Literature DB >> 22443195

The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies.

Lidia Rita Corsini1, Giuseppe Bronte, Marianna Terrasi, Valeria Amodeo, Daniele Fanale, Eugenio Fiorentino, Giuseppe Cicero, Viviana Bazan, Antonio Russo.   

Abstract

INTRODUCTION: miRNAs are noncoding RNAs that target specific mRNA with subsequent regulation of particular genes, implicated in various biological processes. In cancer, miRNAs could show a different expression from normal tissues. miRNAs have a role as oncogenes when they target tumor suppressor genes and similarly they are tumor suppressors when they target oncogenes. AREAS COVERED: In this review, areas covered include the role of miRNAs in cancer diagnosis, prognosis and research for achievement of therapeutic strategies implicating miRNAs in oncology. As biogenesis of miRNAs is fundamental to understand their usefulness, this has also been discussed. Both miRNA expression profiles in cancer tissues and miRNA levels in peripheral blood were studied for improvement in the management of cancer patients. EXPERT OPINION: miRNAs have the potential for better understanding of tumor biology, but could also provide clinical advancement in management and therapy of various malignancies. The possibility of miRNA detection in peripheral blood would allow an eager expansion of their application in various clinical settings for cancer. The applicability of miRNA expression profiles still needs to be defined.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22443195     DOI: 10.1517/14728222.2011.650632

Source DB:  PubMed          Journal:  Expert Opin Ther Targets        ISSN: 1472-8222            Impact factor:   6.902


  60 in total

1.  MicroRNA Expression and Correlation with mRNA Levels of Colorectal Cancer-Related Genes.

Authors:  Farahnaz Moghadamnia; Pegah Ghoraeian; Sara Minaeian; Atefeh Talebi; Farnaz Farsi; Abolfazl Akbari
Journal:  J Gastrointest Cancer       Date:  2020-03

Review 2.  Molecular basis of chronic lymphocytic leukemia diagnosis and prognosis.

Authors:  Mohammad Shahjahani; Javad Mohammadiasl; Fatemeh Noroozi; Mohammad Seghatoleslami; Saeid Shahrabi; Fakhredin Saba; Najmaldin Saki
Journal:  Cell Oncol (Dordr)       Date:  2015-01-07       Impact factor: 6.730

3.  miRNA-202 in bone marrow stromal cells affects the growth and adhesion of multiple myeloma cells by regulating B cell-activating factor.

Authors:  Xianjuan Shen; Yuehua Guo; Jiajia Yu; Jing Qi; Wei Shi; Xinhua Wu; Hongbing Ni; Shaoqing Ju
Journal:  Clin Exp Med       Date:  2015-05-14       Impact factor: 3.984

4.  Association Between Polymorphisms in the Promoter Region of microRNA-34b/c and the Chemoradiotherapy Efficacy for Locally Advanced Esophageal Squamous Cell Carcinoma in Chinese Han Population.

Authors:  Jilisihan Bulibu; Wei Wang; Yong Tang; Na Li; Keyoumu Saifuding
Journal:  Pathol Oncol Res       Date:  2017-12-21       Impact factor: 3.201

5.  Baicalin induced colon cancer cells apoptosis through miR-217/DKK1-mediated inhibition of Wnt signaling pathway.

Authors:  Yanmei Jia; Lirong Chen; Songjia Guo; Yuanhong Li
Journal:  Mol Biol Rep       Date:  2019-02-08       Impact factor: 2.316

6.  Selection of reference genes for miRNA quantitative PCR and its application in miR-34a/Sirtuin-1 mediated energy metabolism in Megalobrama amblycephala.

Authors:  Jie Liu; Erteng Jia; Huajuan Shi; Xiangfei Li; Guangzhen Jiang; Cheng Chi; Wenbin Liu; Dingdong Zhang
Journal:  Fish Physiol Biochem       Date:  2019-05-24       Impact factor: 2.794

Review 7.  Role of microRNA deregulation in the pathogenesis of diffuse large B-cell lymphoma (DLBCL).

Authors:  Krystyna Mazan-Mamczarz; Ronald B Gartenhaus
Journal:  Leuk Res       Date:  2013-09-07       Impact factor: 3.156

8.  MicroRNA-27b exerts an oncogenic function by targeting Fbxw7 in human hepatocellular carcinoma.

Authors:  Xin-Fang Sun; Jin-Ping Sun; Hong-Tao Hou; Ke Li; Xin Liu; Quan-Xing Ge
Journal:  Tumour Biol       Date:  2016-10-04

9.  An integrative bioinformatics analysis identified miR-375 as a candidate key regulator of malignant breast cancer.

Authors:  Jiaxuan Liu; Ping Wang; Ping Zhang; Xinyu Zhang; Hang Du; Qiang Liu; Bo Huang; Caiyun Qian; Shuhua Zhang; Weifeng Zhu; Xiaohong Yang; Yingqun Xiao; Zhuoqi Liu; Daya Luo
Journal:  J Appl Genet       Date:  2019-08-01       Impact factor: 3.240

10.  miR-124 Regulates the Epithelial-Restricted with Serine Box/Epidermal Growth Factor Receptor Signaling Axis in Head and Neck Squamous Cell Carcinoma.

Authors:  Manchao Zhang; Longzhu Piao; Jharna Datta; James C Lang; Xiujie Xie; Theodoros N Teknos; Anna K Mapp; Quintin Pan
Journal:  Mol Cancer Ther       Date:  2015-07-30       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.